Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

TRUST trial further explores efficacy and safety of corifollitropin alfa

July 9, 2010

UDPGT 1-4 gene polymorphism affects lamotrigine pharmacokinetics

July 9, 2010

Aliskiren/amlodipine combination effective in hypertension

July 9, 2010

Intratumoral TG-4023 gene therapy is feasible in patients with liver cancer

July 9, 2010

Phase I and II data reported on blinatumomab in hematological cancers

July 9, 2010

MicroRNA expression profiles associated with malignancy potential of pancreatic cystic tumors

July 9, 2010

First-in-human data presented on oncolytic agent MNRP-1685A

July 8, 2010

CNTO-888 well tolerated in patients with advanced solid tumors

July 8, 2010

Enzastaurin shows potential in phase II follicular lymphoma trial

July 8, 2010

Phase I data reported on PCI-32765 in non-Hodgkin's lymphoma

July 8, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...